![]()
|
|
||||||||
(Received for publication, February 3, 1997, and in revised form, February 18, 1997)
From the Department of Pathology, University of Michigan Medical
School, Ann Arbor, Michigan 48109-0602 and the
§ Department of Molecular Microbiology and Immunology, St.
Louis University Health Sciences Center, St.
Louis, Missouri 63104
Molluscum contagiosum virus proteins MC159 and
MC160 and the equine herpesvirus 2 protein E8 share substantial
homology to the death effector domain present in the adaptor molecule
Fas-associated death domain protein (FADD) and the initiating death
protease FADD-like interleukin-1 Cell suicide is a defense mechanism employed by host cells to
inhibit viral replication and persistence. As a consequence, viruses
have evolved numerous strategies to attenuate apoptosis (1). For
example, the Epstein-Barr virus (EBV) encodes BHRF1, a
homolog of the mammalian anti-apoptosis molecule bcl-2, and the cowpox
virus encodes a serpin-like protein, CrmA, that blocks apoptosis by
inhibiting proteases belonging to the caspase family.
Molluscum contagiosum virus (MCV) is the only poxvirus family member
still associated with human disease (2). It usually causes asymptomatic
cutaneous neoplasms that can spontaneously regress. However, with the
advent of immunocompromised populations, particularly those afflicted
with acquired immunodeficiency syndrome, MCV infection has become a
clinical challenge (3). Unfortunately, due to the inability to grow the
virus in tissue culture cells and the lack of a suitable animal model,
little is known about host-virus relationships (4). Equine herpesvirus
2 (EHV2) is a member of the MCV, surprisingly, does not encode many of the immunoregulatory
molecules present in other poxviruses, especially those that antagonize
the host cytokine-mediated inflammatory response. These include CrmA
and a soluble TNFR-like1 molecule (7). In contrast, EHV2
encodes an interleukin-10-like factor that may attenuate the host
immune response (8). Regardless, MCV and EHV2 do not encode previously
identified inhibitors of apoptosis (1). Instead, MCV and EHV2 encode
novel members of an emerging family of molecules characterized by the
presence of a death effector domain (DED) originally identified in
signaling molecules engaged by the death receptors TNFR-1 and CD-95 (7, 8).
Both TNFR-1 and CD-95 contain a stretch of approximately 60-80 amino
acids within their cytoplasmic domains termed the death domain. Upon
activation the receptor death domains bind to corresponding death
domains within the adaptor molecules TRADD (for TNFR-1) and FADD (for
CD-95) (9-12). Utilizing the same mechanism, TRADD is able in turn to
recruit FADD to the TNFR-1 signaling complex (13). FADD appears to play
a central role as a conduit for death signals from both receptors as
dominant negative versions that retain the death domain but lack the
amino-terminal segment effectively attenuate both TNFR-1- and
CD-95-induced killing (14). Since it is likely that the amino-terminal
domain of FADD functions to engage downstream components of the death
pathway, it has been termed the DED (14). The importance of this domain
was dramatically underscored by the discovery of its presence within
the prodomain of the death protease FLICE (15-17). It appears that the
DED of FADD binds to the corresponding DED motif within the FLICE
prodomain and thereby recruits this death protease to the receptor
signaling complex. Therefore, a homophilic binding mechanism involving
DEDs is responsible for assembly of the receptor death signaling
complex. Disruption of such a complex by DED-containing viral gene
products could potentially abrogate propagation of the death
signal.
Human embryonic kidney
293, 293T, and 293-EBNA cells were cultured in Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum, nonessential amino
acids, L-glutamine, and penicillin/streptomycin. Mammalian
expression vectors encoding TNFR-1, CD-95, FADD, FLICE, MC159, MC160,
E8, and CrmA were cloned into pcDNA3 (Invitrogen). The expression
vector for TRADD was kindly provided by Dr. David Goeddel (Tularik,
Inc.).
Full-length FADD and truncated
N-FADD were expressed as GST-fusion proteins as described previously
(18). [35S]Methionine-radiolabeled MC159 was obtained by
in vitro transcription/translation using the TNT
T7-coupled reticulocyte lysate system (Promega). Binding reactions were
performed as described previously (18).
Transient transfections of 293T cells were performed as
described previously (19). Cells were harvested 40 h following
transfection, immunoprecipitated with the indicated antibodies, and
analyzed by immunoblotting.
For CD-95, TRADD, and FLICE killing,
experiments were performed in 293-EBNA cells and in 293 cells for
TNFR-1 and FADD killing. cDNAs encoding putative apoptosis inducers
(0.5-0.8 µg) and potential inhibitors (2.5 µg) were cotransfected
in each experiment together with the reporter plasmid pCMV
MCV encodes two
closely related proteins: MC159 and MC160 (6). The NH2
termini of the 241-amino acid protein MC159 and the 371-amino acid
protein MC160 contain two motifs homologous to DEDs present at the
NH2 terminus of FADD and repeated in tandem within the
prodomain of FLICE (7). Interestingly, the DED motif is also present
within EHV2-encoded protein E8 (171 amino acids), Kaposi's
sarcoma-associated herpesvirus-encoded protein K13 (139 amino acids),
and bovine herpesvirus 4-encoded protein E1.1 (182 amino acids) (Fig.
1) (20, 21). Unlike the MCV proteins, full-length E8,
K13, and E1.1 encode only DED motifs. K13 encodes one complete and one
incomplete DED, whereas E8 and E1.1 encode two DEDs. Each DED of these
viral proteins contains a highly conserved module RXDL/I(L)
(X is any amino acid) that is also conserved in the DEDs of
FADD and FLICE. It appears that many other herpesviruses also encode
DED-like molecules. Examples include the herpesvirus saimiri protein
VG71 and human herpesvirus 6 protein U15 (22, 23).
The presence of DEDs within E8, MC159, and MC160
suggests that these viral proteins might potentially antagonize the
FADD-FLICE interaction and thereby attenuate TNFR-1- and CD-95-mediated
apoptosis. Indeed, overexpression of MC159 significantly inhibited
TNFR-1- and CD-95-induced cell death (Fig.
2A). The degree of inhibition was
substantially greater than that achieved with the catalytically inactive dominant-negative version of FLICE (data not shown) and comparable in potency with CrmA. MC160 also inhibited TNFR-1- and
CD-95-induced cell death (Fig. 2B), as did E8 (Fig.
2C).
Additional studies were undertaken to delineate the point
at which MC159 and E8 were exerting their inhibitory effect on the TNFR-1- and CD-95-induced death pathways. As shown in Fig.
3, both MC159 and E8 significantly blocked both TRADD
and FADD killing, suggesting that these inhibitors must function
downstream of these adaptor molecules. In contrast, MC159 and E8 did
not inhibit FLICE-induced death, suggesting that they must act upstream
of active FLICE. The overexpression of FLICE zymogen results in
autoactivation to the active protease that is potently inhibited by the
viral serpin CrmA (Fig. 3C).
Binding studies were
undertaken to investigate the potential mechanism utilized by E8 and
MC159 to attenuate TNFR-1- and CD-95-induced cell death (Fig.
4). Radiolabeled in vitro translated MC159
was precipitated with various GST-fusion proteins immobilized onto glutathione-Sepharose beads, including GST-FADD, GST-NFADD containing only the NH2-terminal DED (amino acid residues: 1-82), or
GST alone (Fig. 4A). As expected from the homophilic binding
nature of DEDs, MC159 strongly bound GST-FADD and GST-NFADD, but not GST alone.
To demonstrate the association of the viral inhibitory molecules with
FADD or FLICE in vivo, 293 cells were transiently
transfected with expression constructs encoding epitope-tagged versions
of the respective molecules (Fig. 4). Consistent with the in
vitro binding results, MC159 precipitated with FADD (Fig.
4B), but not with FLICE (data not shown). Conversely, E8
strongly associated with FLICE (Fig. 4C), but not with FADD
(data not shown). This binding specificity of MC159 and E8 suggested
that distinct mechanisms were employed by these two inhibitors. MC159
binds to FADD and presumably blocks its interaction with FLICE. The
reverse is probably true for E8 in that it binds FLICE and inhibits its
interaction with FADD. However, when FLICE is overexpressed (upon
transfection), the binding of E8 is unable to overcome the propensity
of this caspase to autoactivate (Fig. 3C). Therefore, once
FLICE is active, E8 has no inhibitory influence. Regardless, either
mechanism would disrupt the assembly of the receptor·FADD· FLICE
signaling complex and abrogate activation of downstream caspases.
Further studies will be needed to substantiate these proposed
mechanisms.
We thank Dr. Andrew Davison for providing the
EHV2 DNA; Arul Chinnaiyan, Marta Muzio, James Pan, and Karen O'Rourke
for providing reagents and helpful discussions; and Ian Jones for his
expertise in preparing the figures.
Volume 272, Number 15,
Issue of April 11, 1997
pp. 9621-9624
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
,
,
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
-converting enzyme (FLICE)
(caspase-8). FADD and FLICE participate in generating the death signal
from both tumor necrosis factor receptor-1 (TNFR-1) and the CD-95
receptor. The flow of death signals from TNFR-1 occurs through the
adaptor molecule tumor necrosis factor receptor-associated death domain protein (TRADD) to FADD to FLICE, whereas for CD-95 the receptor directly communicates with FADD and then FLICE. MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by
overexpression of the downstream adaptors TRADD and FADD. Neither viral
molecule, however, inhibited FLICE-induced killing, consistent with an
inhibitory action upstream of the active death protease. These data
suggest the existence of a novel strategy employed by viruses to
attenuate host immune killing mechanisms. Given that bovine herpesvirus
4 protein E1.1 and Kaposi's sarcoma associated-herpesvirus protein K13
also possess significant homology to the viral inhibitory molecules
MC159, MC160, and E8, it may be that this class of proteins is used
ubiquitously by viruses to evade host defense.
-herpesvirus subfamily that also
includes herpesvirus saimiri, EBV, Kaposi's sarcoma-associated
herpesvirus (KSHV), and bovine herpesvirus 4 (5, 6). Although EHV2 is
ubiquitously distributed and has been implicated as a pathogen in
immunosuppressed states, its mode of evading the host immune response
is uncertain. However, the recent availability of the MCV and EHV2
genome sequences has begun to identify genes that suggest potential
pathogenic mechanisms (7, 8).
Cell Lines and Expression Vectors
-galactosidase. Cells were fixed and stained 24-30 h following
transfection. The percentage of apoptotic cells was determined by
calculating the fraction of round membrane-blebbed blue cells as a
function of total blue cells. All assays were evaluated in duplicate
and the mean and standard deviation calculated.
E8 and MC159 Are Members of the DED Family
Fig. 1.
Sequence alignment of viral DED-containing
molecules. The DED motifs contained within the adaptor molecule
FADD and the initiating caspase FLICE were aligned to DED-like motifs
present in the molluscum contagiosum virus proteins MC159 and MC160,
bovine herpesvirus 4 protein E1.1, equine herpesvirus 2 protein E8, and the Kaposi's sarcoma-associated virus protein K13. The conserved module RXDLL is boxed.
[View Larger Version of this Image (50K GIF file)]
Fig. 2.
MC159, MC160, and E8 inhibit TNFR-1- and
CD-95-induced apoptosis. Overexpression of MC159 (A),
MC160 (B), and E8 (C) inhibit CD-95- and
TNFR-1-induced cell death. 293 or 293-EBNA cells were cotransfected
with indicated plasmid together with the reporter construct pCMV
-galactosidase. Cells were fixed and stained 24-30 h following
transfection. The data shown are the percentage of blebbing blue cells
as a function of total number of blue cells counted.
[View Larger Version of this Image (27K GIF file)]
Fig. 3.
MC159 and E8 inhibit both TRADD and FADD but
not FLICE killing. MC159 and E8 inhibit TRADD (A) and
FADD (B) killing but fail to inhibit FLICE killing
(C). 293 or 293-EBNA cells were cotransfected with indicated
plasmid together with the reporter construct pCMV
-galactosidase.
Cells were fixed and stained 24 h following transfection. The data
shown are the percentage of blebbing blue cells as a function of total
number of blue cells counted.
[View Larger Version of this Image (21K GIF file)]
Fig. 4.
MC159 binds FADD, whereas E8 binds FLICE.
A, interaction of radiolabeled in vitro
translated MC159 with GST-FADD and GST-N-FADD immobilized onto
glutathione-Sepharose beads. 2 µl of 35S-labeled
translation reaction was directly loaded as a control, while 5 µl was
used in each binding reaction. B, MC159 binds FADD. 293T
cells were cotransfected with Myc-tagged MC159 and AU1-tagged FADD.
40 h following transfection, cells lysates were immunoprecipitated and immunoblotted with the indicated antibodies. C, E8 binds
FLICE. 293T cells were cotransfected with Myc-tagged E8 and FLAG-tagged FLICE.
[View Larger Version of this Image (12K GIF file)]
*
This work was supported by National Institutes of Health
Grants AG13671 and ES08111.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Equal contribution was made by the first two authors.
¶
To whom correspondence should be addressed: Dept. of
Pathology, The University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109-0602. Tel.: 313-647-0264; Fax: 313-764-4308; E-mail: vmdixit{at}umich.edu.
1
The abbreviations used are: TNFR-1, tumor
necrosis factor receptor 1; FADD, Fas-associated death domain protein;
FLICE, FADD-like interleukin-1
-converting enzyme; TRADD, tumor
necrosis factor receptor-associated death domain protein; MCV,
molluscum contagiosum virus; EHV2, equine herpesvirus 2; KSHV,
Kaposi's sarcoma-associated herpesvirus; DED, death effector
domain.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. V. Richter and D. J. Topham The {alpha}1beta1 Integrin and TNF Receptor II Protect Airway CD8+ Effector T Cells from Apoptosis during Influenza Infection J. Immunol., October 15, 2007; 179(8): 5054 - 5063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Balachandran, T. Venkataraman, P. B. Fisher, and G. N. Barber Fas-Associated Death Domain-Containing Protein-Mediated Antiviral Innate Immune Signaling Involves the Regulation of Irf7 J. Immunol., February 15, 2007; 178(4): 2429 - 2439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Braeuer, C. Buneker, A. Mohr, and R. M. Zwacka Constitutively Activated Nuclear Factor-{kappa}B, but not Induced NF-{kappa}B, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells Mol. Cancer Res., October 1, 2006; 4(10): 715 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Elankumaran, D. Rockemann, and S. K. Samal Newcastle Disease Virus Exerts Oncolysis by both Intrinsic and Extrinsic Caspase-Dependent Pathways of Cell Death. J. Virol., August 1, 2006; 80(15): 7522 - 7534. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-Y. Li, P. D. Jeffrey, J. W. Yu, and Y. Shi Crystal Structure of a Viral FLIP: INSIGHTS INTO FLIP-MEDIATED INHIBITION OF DEATH RECEPTOR SIGNALING J. Biol. Chem., February 3, 2006; 281(5): 2960 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakagiri, A. Murakami, S. Takada, T. Akiyama, and S. Yonehara Viral FLIP Enhances Wnt Signaling Downstream of Stabilized {beta}-Catenin, Leading to Control of Cell Growth Mol. Cell. Biol., November 1, 2005; 25(21): 9249 - 9258. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chugh, H. Matta, S. Schamus, S. Zachariah, A. Kumar, J. A. Richardson, A. L. Smith, and P. M. Chaudhary Constitutive NF-{kappa}B activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice PNAS, September 6, 2005; 102(36): 12885 - 12890. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, P. Liston, and R. W. Moyer Functional Analysis of the Inhibitor of Apoptosis (iap) Gene Carried by the Entomopoxvirus of Amsacta moorei J. Virol., February 15, 2005; 79(4): 2335 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-G. Jin, A. Kurakin, N. Benhaga, K. Abe, M. Mohseni, F. Sandra, K. Song, B. K. Kay, and R. Khosravi-Far Fas-associated Protein with Death Domain (FADD)-independent Recruitment of c-FLIPL to Death Receptor 5 J. Biol. Chem., December 31, 2004; 279(53): 55594 - 55601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippova, L. Parkhurst, and P. J. Duerksen-Hughes The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis J. Biol. Chem., June 11, 2004; 279(24): 25729 - 25744. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matta, Q. Sun, G. Moses, and P. M. Chaudhary Molecular Genetic Analysis of Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein-induced NF-{kappa}B Activation J. Biol. Chem., December 26, 2003; 278(52): 52406 - 52411. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Sun, S. Zachariah, and P. M. Chaudhary The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-{kappa}B Activation J. Biol. Chem., December 26, 2003; 278(52): 52437 - 52445. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins KSHV vFLIP binds to IKK-{gamma} to activate IKK J. Cell Sci., September 15, 2003; 116(18): 3721 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vaidyanathan and J. W. Ramos RSK2 Activity Is Regulated by Its Interaction with PEA-15 J. Biol. Chem., August 22, 2003; 278(34): 32367 - 32372. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Sun, H. Matta, and P. M. Chaudhary The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation Blood, March 1, 2003; 101(5): 1956 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Perez and E. White E1A Sensitizes Cells to Tumor Necrosis Factor Alpha by Downregulating c-FLIPS J. Virol., February 15, 2003; 77(4): 2651 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nitobe, S. Yamaguchi, M. Okuyama, N. Nozaki, M. Sata, T. Miyamoto, Y. Takeishi, I. Kubota, and H. Tomoike Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes Cardiovasc Res, January 1, 2003; 57(1): 119 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the Ikappa B Kinase Complex J. Biol. Chem., April 12, 2002; 277(16): 13745 - 13751. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Garvey, J. Bertin, R. M. Siegel, G.-h. Wang, M. J. Lenardo, and J. I. Cohen Binding of FADD and Caspase-8 to Molluscum Contagiosum Virus MC159 v-FLIP Is Not Sufficient for Its Antiapoptotic Function J. Virol., January 15, 2002; 76(2): 697 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krueger, S. Baumann, P. H. Krammer, and S. Kirchhoff FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis Mol. Cell. Biol., December 15, 2001; 21(24): 8247 - 8254. [Full Text] [PDF] |
||||
![]() |
S. T. Wasilenko, A. F. A. Meyers, K. Vander Helm, and M. Barry Vaccinia Virus Infection Disarms the Mitochondrion-Mediated Pathway of the Apoptotic Cascade by Modulating the Permeability Transition Pore J. Virol., December 1, 2001; 75(23): 11437 - 11448. [Abstract] [Full Text] |
||||
![]() |
N. Neznanov, A. Kondratova, K. M. Chumakov, B. Angres, B. Zhumabayeva, V. I. Agol, and A. V. Gudkov Poliovirus Protein 3A Inhibits Tumor Necrosis Factor (TNF)-Induced Apoptosis by Eliminating the TNF Receptor from the Cell Surface J. Virol., November 1, 2001; 75(21): 10409 - 10420. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malhotra, Z. Lin, C. Vincenz, and F. C. Brosius III Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1596 - C1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Snow, L. J. Chen, R. R. Nepomuceno, S. M. Krams, C. O. Esquivel, and O. M. Martinez Resistance to Fas-Mediated Apoptosis in EBV-Infected B Cell Lymphomas Is Due to Defects in the Proximal Fas Signaling Pathway J. Immunol., November 1, 2001; 167(9): 5404 - 5411. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang and B. Moss Correspondence of the Functional Epitopes of Poxvirus and Human Interleukin-18-Binding Proteins J. Virol., October 15, 2001; 75(20): 9947 - 9954. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Pettersen, G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie CD99 Signals Caspase-Independent T Cell Death J. Immunol., April 15, 2001; 166(8): 4931 - 4942. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Droin, F. Bichat, C. Rebe, A. Wotawa, O. Sordet, A. Hammann, R. Bertrand, and E. Solary Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells Blood, March 15, 2001; 97(6): 1835 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glykofrydes, H. Niphuis, E. M. Kuhn, B. Rosenwirth, J. L. Heeney, J. Bruder, G. Niedobitek, I. Müller-Fleckenstein, B. Fleckenstein, and A. Ensser Herpesvirus Saimiri vFLIP Provides an Antiapoptotic Function but Is Not Essential for Viral Replication, Transformation, or Pathogenicity J. Virol., December 15, 2000; 74(24): 11919 - 11927. [Abstract] [Full Text] |
||||
![]() |
B. B Aggarwal Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa B Ann Rheum Dis, November 1, 2000; 59(90001): i6 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imanishi, C. E. Murry, H. Reinecke, T. Hano, I. Nishio, W.C. Liles, L. Hofsta, K. Kim, K. D. O'Brien, S. M. Schwartz, et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues Cardiovasc Res, October 1, 2000; 48(1): 101 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Clarke, S. M. Meintzer, S. Gibson, C. Widmann, T. P. Garrington, G. L. Johnson, and K. L. Tyler Reovirus-Induced Apoptosis Is Mediated by TRAIL J. Virol., September 1, 2000; 74(17): 8135 - 8139. [Abstract] [Full Text] |
||||
![]() |
J. W. Ramos, P. E. Hughes, M. W. Renshaw, M. A. Schwartz, E. Formstecher, H. Chneiweiss, and M. H. Ginsberg Death Effector Domain Protein PEA-15 Potentiates Ras Activation of Extracellular Signal Receptor-activated Kinase by an Adhesion-independent Mechanism Mol. Biol. Cell, September 1, 2000; 11(9): 2863 - 2872. [Abstract] [Full Text] |
||||
![]() |
K. Nagaraju, L. Casciola-Rosen, A. Rosen, C. Thompson, L. Loeffler, T. Parker, C. Danning, P. J. Rochon, J. Gillespie, and P. Plotz The Inhibition of Apoptosis in Myositis and in Normal Muscle Cells J. Immunol., May 15, 2000; 164(10): 5459 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kumar, T. L. Whiteside, and U. Kasid Identification of a Novel Tumor Necrosis Factor-alpha -inducible Gene, SCC-S2, Containing the Consensus Sequence of a Death Effector Domain of Fas-associated Death Domain-like Interleukin- 1beta -converting Enzyme-inhibitory Protein J. Biol. Chem., January 28, 2000; 275(4): 2973 - 2978. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Lurain, K. S. Kapell, D. D. Huang, J. A. Short, J. Paintsil, E. Winkfield, C. A. Benedict, C. F. Ware, and J. W. Bremer Human Cytomegalovirus UL144 Open Reading Frame: Sequence Hypervariability in Low-Passage Clinical Isolates J. Virol., December 1, 1999; 73(12): 10040 - 10050. [Abstract] [Full Text] |
||||
![]() |
M. Sturzl, C. Hohenadl, C. Zietz, E. Castanos-Velez, A. Wunderlich, G. Ascherl, P. Biberfeld, P. Monini, P. J. Browning, and B. Ensoli Expression of K13/v-FLIP Gene of Human Herpesvirus 8 and Apoptosis in Kaposi's Sarcoma Spindle Cells J Natl Cancer Inst, October 20, 1999; 91(20): 1725 - 1733. [Abstract] [Full Text] [PDF] |
||||
|
|